Phase I/II trial of sorafenib and CCI-779 in patients with recurrent glioblastoma (GBM)

Jaeckle, K. ,  Anderson, K. ,  Sarkaria, J. ,  Decker, P. ,  Buckner, J. ... -  ICTT   -    -  2008    

Abstract -  Primary -  Preliminary -  Neuro-Onc -  NCCTG-N0572